ABSTRACT
OBJECTIVE: The aim of the present study was to investigate the possibility to predict the histopathological features of breast and metastatic lymph nodes and survey and prognosis of patients and likelihood of being a predictive factor for treatment by using Ki67 immunohistochemical stain. MATERIALS AND METHODS: 95 patients who were admitted to Uludag University Medical Faculty, Department of General Surgery with a diagnosis of stage II-III breast cancer between dates May 1997 and December 2002 were retrospectively evaluated with respect to breast cancer related prognostic factors treatments and last-control related data. Ki67 immunohistochemical staining was performed to appropriate specimens using Streptavidin-biotin technique. Ki67 was reported as the proliferation index, and the number of stained nuclei were stated to be / 1000. RESULTS: In the evaluation of the lymph node by univariate analysis, we ascertained that duration of survival is shorter above the 227 cut-off value for Ki67 proliferative index. Length of survival of patients with tumor Ki67 proliferative index below 141 and with no distant metastasis was established to be better. Ki67 proliferative index in the lymph node was detected to increase more with increasing histological and nuclear grade, estrogen and progesterone receptor negativity and at stage III. CONCLUSION: Since numerous factors are effective on breast cancer, each patient and tumor behaves differently. A lot of prognostic factors are taken into account while treatment choice is determined. We may have information on the biological behavior of the tumor in patients who underwent sentinel lymph node biopsy or axillary dissection in staining with Ki67 pattern (Tab. 5, Fig. 3, Ref. 13).
Subject(s)
Breast Neoplasms/pathology , Ki-67 Antigen/analysis , Lymphatic Metastasis/pathology , Adult , Aged , Aged, 80 and over , Axilla/pathology , Biomarkers, Tumor/analysis , Female , Humans , Immunohistochemistry , Middle Aged , Neoplasm Staging , Predictive Value of Tests , Prognosis , Survival RateABSTRACT
Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare complication of cellular blood component transfusion that produces a graft-versus-host clinical picture with concomitant bone marrow aplasia. We report the case of 2 patients with severe combined immunodeficiency (SCID) who developed TA-GvHD. Both patients had been given nonirradiated erythrocyte suspension before the diagnosis of SCID. Although one of them was aged 12 months, he had still not been diagnosed as having severe T-cell deficiency at the time of transfusion. Both patients presented similar signs and symptoms (fever, skin rash, diarrhea, pancytopenia, and icterus). Skin biopsies demonstrated Grade II GVHD involvement. In both cases, sepsis and septic shock developed, with progression to multiorgan failure. Unfortunately, the 2 patients died, despite prompt, appropriate sepsis treatment and immunomodulatory therapy. TA-GVHD must be considered in the differential diagnosis of patients who present fever, pancytopenia, diarrhea, skin rash and icterus, and the transfusion history must be questioned.
Subject(s)
Erythrocyte Transfusion/adverse effects , Graft vs Host Disease/diagnosis , Graft vs Host Disease/etiology , Severe Combined Immunodeficiency/therapy , Skin/immunology , Early Diagnosis , Exanthema , Fatal Outcome , Graft vs Host Disease/physiopathology , Graft vs Host Disease/prevention & control , Humans , Infant , Male , Multiple Organ Failure , Recurrence , Respiratory Tract Infections , Severe Combined Immunodeficiency/physiopathology , Shock, Septic , Skin/pathologySubject(s)
Facial Dermatoses/diagnosis , Keratosis, Seborrheic/diagnosis , Aged , Diagnosis, Differential , Female , HumansSubject(s)
Bone Marrow Neoplasms/pathology , Carcinoma, Small Cell/pathology , Leukemia , Lung Neoplasms/pathology , Acute Disease , Bone Marrow Neoplasms/diagnostic imaging , Bone Marrow Neoplasms/secondary , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/diagnostic imaging , Humans , Leukemia/diagnostic imaging , Leukemia/pathology , Lung Neoplasms/complications , Lung Neoplasms/diagnostic imaging , Male , Middle Aged , RadiographyABSTRACT
Rowell's syndrome (RS) is a rare presentation of lupus erythematosus (LE) with erythema multiforme-like lesions associated with antinuclear, anti-La (SS-B)/anti-Ro (SS-A) antibodies and rheumatoid factor (RF) positivity. This syndrome is suggested to be a different variant of cutaneous lupus erythematosus by some authors in literature. Here we present a 64-year-old woman with LE and a 51-year-old woman with LE and Sjögren syndrome (SS) who had erythema multiforme-like eruptions and discuss the coexistence of lupus erythematosus and erythema multiforme.